News

Discover Insights from Pyxis Oncology at Upcoming Events

Discover Insights from Pyxis Oncology at Upcoming Events

Participation in Key Conferences

Pyxis Oncology, Inc. (Nasdaq: PYXS), a pioneering clinical-stage company specializing in antibody-drug conjugate (ADC) therapeutics aimed at challenging cancers, has recently announced participation in several notable conferences that investors and industry professionals should not miss.

Upcoming Investor Conferences

During these engagements, Lara S. Sullivan, M.D., the accomplished President and CEO of Pyxis Oncology, will be at the forefront, actively participating in the following investor events:

2025 Cantor Global Healthcare Conference

This highly anticipated conference will take place in New York City on a selected Wednesday in September, with a scheduled fireside chat at 2:45 p.m. ET, alongside opportunities for one-on-one investor meetings.

H.C. Wainwright 27th Annual Global Investment Conference

Another significant event will be hosted the following Monday in September, where Dr. Sullivan will once again participate in a fireside chat and exclusive discussions with investors at 10:30 a.m. ET.

Industry Engagements

It’s not just investor meetings for Pyxis. The company is also gearing up for an essential industry conference:

2nd Annual ADC and Novel Conjugates Partnering and Investment Summit

On a Tuesday in September, Pyxis will present at this summit specific to ADCs in Boston. The company will showcase its pioneering research without a webcast option, allowing direct engagement with attendees at 3:20 p.m. ET.

Accessing Live Webcasts

In addition to in-person presentations, stakeholders can look forward to live webcasts and replays of the fireside chats from the Cantor and H.C. Wainwright conferences. These sessions will be accessible through the Investor Relations section on the Pyxis Oncology website, ensuring that interested parties remain informed on the company’s latest developments.

About Pyxis Oncology, Inc.

At the core of its mission, Pyxis Oncology is dedicated to developing innovative treatment options for challenging and hard-to-treat cancers. The company is at the forefront of creating advanced therapies that have shown promise in diverse settings, including monotherapy and combination therapies. Its leading candidate, micvotabart pelidotin (MICVO), has been undergoing rigorous evaluation in various ongoing Phase 1 clinical studies across multiple solid tumor types. The focus is heavily directed toward recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) due to a compelling signal from preliminary studies.

Moreover, Pyxis has initiated a Phase 1/2 combination trial using MICVO along with Merck's renowned anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). This innovative approach hopes to address patients battling R/M HNSCC and several other advanced solid tumors. The implications of these studies could be transformative for cancer therapy.

Contact Information

If you wish to learn more about Pyxis Oncology or have inquiries, feel free to reach out:

Pyxis Oncology Contact
Jitu Wadhane
Principal Financial and Accounting Officer
Email: IR@pyxisoncology.com

Media Contact
Molly Devlin
Real Chemistry
Email: mdevlin@realchemistry.com

Frequently Asked Questions

What is Pyxis Oncology known for?

Pyxis Oncology is recognized for developing innovative antibody-drug conjugate (ADC) therapeutics aimed at treating difficult cancers.

Who will represent Pyxis Oncology at the conferences?

Dr. Lara S. Sullivan, the President and CEO, will represent Pyxis Oncology at the upcoming conferences.

What are the notable upcoming conferences for Pyxis Oncology?

Key conferences include the Cantor Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference.

When will the company present?

Presentations will occur in early September, with specific times listed for each event.

How can I learn more about Pyxis Oncology?

More information about Pyxis Oncology can be found on their official website and through their Investor Relations section.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 190

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 218

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 34

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 212

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Sussex County Data Breach Raises Security Concerns

Updated Category News Views 165

The Digital Fiasco: A Wake-Up Call Straight out of Sussex County in good ol' New Jersey, we’re staring down another data breach, folks. When you hear about a data privacy incident, there's always that same sinking feeling of another layer of personal security peeled away. This time, the Sussex County Prosecutor's Office got caught in the crossfire, with personal info...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 219

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 161

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 122

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 187

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 143

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading

Top 5 Most Recently Viewed Articles

StickIt Technologies Pursues Corporate Restructuring Plan

Updated Category News Views 171

StickIt Technologies Announces Strategic Corporate Moves Vancouver, BC - StickIt Technologies Inc. (the "Company" or "STKT"), a leading parent company of an Israeli technology and cannabinoid firm, has recently made significant strides toward improving its market position. The Company has entered into a non-binding letter of intent ("LOI") aimed at reorganizing its...

Continue Reading
Tricia Quinn Joins Michael Baker International as VP, Enhancing Sectors

Updated Category News Views 383

Tricia Quinn Appointed at Michael Baker International Michael Baker International, a recognized leader in engineering and consulting services, has recently appointed Tricia Quinn, AAIA, MS, as the new Vice President of Aerospace and Healthcare Sectors. With 28 years of extensive leadership experience in both sectors, her role is expected to significantly impact the...

Continue Reading
Exploring Sage Therapeutics: Insights on Their Upcoming Merger

Updated Category News Views 186

Understanding the Merger of Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is set to engage in a notable transaction with Supernus Pharmaceuticals, Inc. This merger has garnered attention as it proposes significant financial implications for its shareholders. The proposal outlines the sale of Sage Therapeutics, which will see existing shareholders entitled to...

Continue Reading
New Pool Playset: Safe, Fun, Affordable—A Game Changer?

Updated Category News Views 16

Bring the Waterpark Experience Home with JASMINE DREAM POOLS Who needs to shell out a small fortune to take the kids to a waterpark when you can have the fun right in your own backyard? Enter JASMINE DREAM POOLS, a fresh, patent-pending invention designed to jazz up those long summer days with exactly that idea in mind. It's portable, easy to set up, and promises to...

Continue Reading
Houdini II Dares Destiny in High-Flying Live Escape

Updated Category News Views 157

Ready or Not, Appleton Witnesses Magic Under the Stars Jumping into the unknown isn't everyone's cup of tea, let alone doing so while dangling 80 feet high with nothing but air between you and a hard-hitting reality. This is exactly what's on Houdini II's menu for the Society of American Magicians Convention. He's not just juggling risk; he's owning it, in a tribute thick...

Continue Reading